Cerus (CERS) Amortization of Deferred Charges (2019 - 2026)
Cerus' (CERS) quarterly Amortization of Deferred Charges came in at -$694000.0 in Q2 2026, up 3.21% year-over-year from -$672429.7 in Q2 2025, and down 4.05% quarter-over-quarter from -$667000.0 in Q1 2026.
Powered by 
Analysis
Cerus (CERS) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Cerus has disclosed Amortization of Deferred Charges across 8 years of filings, most recently posting -$694000.0 for Q2 2026.
- In Q2 2026, Amortization of Deferred Charges rose 3.21% year-over-year to -$694000.0; the TTM figure through Jun 2026 stood at -$2.6 million (up 1.27% YoY), while the FY2025 annual figure was -$2.5 million, down 2.01% from the prior year.
- Amortization of Deferred Charges came in at -$694000.0 for Q2 2026 at Cerus, down from -$667000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of -$308000.0 in Q2 2022 to a low of -$745000.0 in Q4 2023.
- Average Amortization of Deferred Charges over 5 years is -$569888.9, with a median of -$591000.0 recorded in 2023.
- Year-over-year, Amortization of Deferred Charges slumped 90.58% in 2023 and climbed 25.77% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at -$547000.0 in 2022, then slumped by 36.2% to -$745000.0 in 2023, then rose by 25.77% to -$553000.0 in 2024, then fell by 11.21% to -$615000.0 in 2025, then retreated by 12.85% to -$694000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were -$694000.0 in Q2 2026, -$667000.0 in Q1 2026, and -$615000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -694,000.00 |
| Mar 31, 2026 | -667,000.00 |
| Dec 31, 2025 | -615,000.00 |
| Sep 30, 2025 | -581,000.00 |
| Jun 30, 2025 | -717,000.00 |
| Mar 31, 2025 | -619,000.00 |
| Dec 31, 2024 | -553,000.00 |
| Sep 30, 2024 | -701,000.00 |
| Jun 30, 2024 | -633,000.00 |
| Mar 31, 2024 | -595,000.00 |
| Dec 31, 2023 | -745,000.00 |
| Sep 30, 2023 | -505,000.00 |
| Jun 30, 2023 | -587,000.00 |
| Mar 31, 2023 | -471,000.00 |
| Dec 31, 2022 | -547,000.00 |
| Sep 30, 2022 | -324,000.00 |
| Jun 30, 2022 | -308,000.00 |
| Mar 31, 2022 | -396,000.00 |
| Dec 31, 2021 | -361,000.00 |
| Sep 30, 2021 | -355,000.00 |